Characteristics of patients with chronic kidney disease and Type 2 diabetes initiating finerenone in the USA: a multi-database, cross-sectional study

• Autores principales: David Vizcaya (Autor), Csaba P Kovesdy (Autor), Andres Reyes (Autor), Elena Pessina (Autor), Pau Pujol (Autor), Glen James (Autor), Nikolaus G Oberprieler (Autor)
• Formato: Libro
• Publicado: Becaris Publishing Limited, 2023-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Aim: Finerenone is safe and efficacious for treating patients with chronic kidney disease (CKD) and Type 2 diabetes (T2D). Evidence on the use of finerenone in clinical practice is lacking. Objective: To describe demographic and clinical characteristics of early adopters of finerenone in the United...